Aumenta le possibilità di ricevere una risposta da questo datore di lavoro
Il tuo curriculum e una lettera di presentazione personalizzati, che corrispondono esattamente a ciò che sta cercando.
MoonLake Immunotherapeutics seeks an Associate Director of Marketing Operations & Launch Excellence to Own the integrated launch and readiness plan from BLA through launch, aligning Marketing with Regulatory, Medical, Sales and Market Access. You will drive governance, tracking and cross‑functional execution to ensure milestones are met and risks are mitigated.
The role requires 5+ years in pharma/biotech marketing or operations, with product launch experience and strong MLR leadership.
The Associate Director, Marketing Operations & Launch Excellence will own the integrated launch and readiness plan, aligning marketing and cross-functional partners to ensure critical milestones are achieved from BLA through launch. This individual will drive governance and cross-functional execution through a clear tracking system, ensuring timelines, accountabilities, and dependencies are transparent and actively managed. This role will also lead launch readiness meetings and sub-teams, serving as the operational backbone that keeps the organization coordinated and on track through launch. This individual will report to the Vice President, Marketing.
MoonLake is a dynamic and innovative company pushing the boundaries of possibility, and we are looking for passionate individuals to join our stellar team.
An exciting job opportunity awaits you!
Learning Environment: An opportunity to learn and grow alongside experienced professionals in a supportive and innovative biotech environment.
Impactful Work: Contribute to ground‑breaking projects that have the potential to transform global healthcare.
Flexibility and Balance: Enjoy a healthy work‑life balance while making meaningful contributions to our team.
Career Growth: A clear path for career progression, with the chance to take on more responsibilities as you develop your skills.
MoonLake Immunotherapeutics is a clinical‑stage biopharmaceutical company unlocking the potential of sonelokimab, a novel investigational Nanobody® for the treatment of the inflammatory disease, to revolutionize outcomes for patients.
We continue to make significant progress in our Global Clinical Development Programs. The company’s focus is on inflammatory diseases with a major unmet need, including hidradenitis suppurativa and psoriatic arthritis – conditions affecting millions of people worldwide with a large need for improved treatment options.
MoonLake was founded in 2021 and is headquarted in Zug, with hubs in Cambridge & Porto.
Further information is available at www.moonlaketx.com